Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors

被引：0
|
作者：
Nair, GV
Gurbel, PA
O'Connor, CM
Gattis, WA
Murugesan, SR
Serebruany, VL
机构：
[1] Sinai Hosp, Thrombosis Res Ctr, Baltimore, MD 21215 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1999年 / 84卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
There is substantial clinical evidence that the incidence of depression and mortality after acute coronary events are strongly related. As mediators of coronary thrombosis, platelets May represent a link between these events, and could be possibly targeted by therapy with serotonin reuptake inhibitors.
引用
收藏
页码：321 / +
页数：4
相关论文
共 50 条
  • [41] The economics of selective serotonin reuptake inhibitors in depression - A critical review
    Frank, L
    Revicki, DA
    Sorensen, SV
    Shih, YCT
    CNS DRUGS, 2001, 15 (01) : 59 - 83
  • [42] Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety
    Kronenberg, Sefi
    Frisch, Amos
    Rotberg, Beni
    Carmel, Miri
    Apter, Alan
    Weizman, Abraham
    PHARMACOGENOMICS, 2008, 9 (11) : 1725 - 1736
  • [43] The selective serotonin reuptake inhibitors controversy in the treatment of depression in children
    Weller E.B.
    Tucker S.
    Weller R.A.
    Current Psychiatry Reports, 2005, 7 (2) : 87 - 90
  • [44] Use of selective serotonin reuptake inhibitors in childhood depression - Reply
    Whittington, CJ
    Kendall, T
    Fonagy, P
    Cottrell, D
    Cotgrove, A
    LANCET, 2004, 364 (9435): : 661 - 661
  • [45] Selective serotonin reuptake inhibitors and vasopressin: an intersection of depression and preeclampsia
    Vignato, Julie
    Scroggins, Sabrina
    Brandt, Debra
    Thomas, Kellie
    Santillan, Donna
    Santillan, Mark
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S99 - S99
  • [46] Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression
    Mourilhe, P
    Stokes, PE
    DRUG SAFETY, 1998, 18 (01) : 57 - 82
  • [47] Controversy revisited: selective serotonin reuptake inhibitors in paediatric depression
    Andrade, Chittaranjan
    Bhakta, Savita G.
    Singh, Nagendra M.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2006, 7 (04): : 251 - 260
  • [48] Risks and Benefits of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression
    Patricia Mourilhe
    Peter E. Stokes
    Drug Safety, 1998, 18 : 57 - 82
  • [49] Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
    Briley, Mike
    Moret, Chantal
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 647 - 655
  • [50] Risperidone augmentation of selective serotonin reuptake inhibitors in major depression
    Ostroff, RB
    Nelson, JC
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (04) : 256 - 259
12345